Search by Drug Name or NDC
NDC 46122-0660-62 Allergy Multi Symptom 325; 2; 5 mg/1; mg/1; mg/1 Details
Allergy Multi Symptom 325; 2; 5 mg/1; mg/1; mg/1
Allergy Multi Symptom is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by AMERISOURCE BERGEN. The primary component is ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Acetaminophen is used to relieve mild to moderate pain from headaches, muscle aches, menstrual periods, colds and sore throats, toothaches, backaches, and reactions to vaccinations (shots), and to reduce fever. Acetaminophen may also be used to relieve the pain of osteoarthritis (arthritis caused by the breakdown of the lining of the joints). Acetaminophen is in a class of medications called analgesics (pain relievers) and antipyretics (fever reducers). It works by changing the way the body senses pain and by cooling the body.
Related Packages: 46122-0660-62Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Acetaminophen
Chlorpheniramine relieves red, itchy, watery eyes; sneezing; itchy nose or throat; and runny nose caused by allergies, hay fever, and the common cold. Chlorpheniramine helps control the symptoms of cold or allergies but will not treat the cause of the symptoms or speed recovery. Chlorpheniramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 46122-0660-62Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Chlorpheniramine
Phenylephrine is used to relieve nasal discomfort caused by colds, allergies, and hay fever. It is also used to relieve sinus congestion and pressure. Phenylephrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Phenylephrine is in a class of medications called nasal decongestants. It works by reducing swelling of the blood vessels in the nasal passages.
Related Packages: 46122-0660-62Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Phenylephrine
Product Information
| NDC | 46122-0660 |
|---|---|
| Product ID | 46122-660_fe3f1cdf-77d5-7d7e-e053-6394a90a6ef1 |
| Associated GPIs | 43994003100315 |
| GCN Sequence Number | 047013 |
| GCN Sequence Number Description | phenylephrine/acetaminophn/cpm TABLET 5-325-2MG ORAL |
| HIC3 | B3O |
| HIC3 Description | 1ST GEN ANTIHISTAMINE-DECONGESTANT-ANALGESIC COMB |
| GCN | 85915 |
| HICL Sequence Number | 000435 |
| HICL Sequence Number Description | PHENYLEPHRINE HCL/ACETAMINOPHEN/CHLORPHENIRAMINE |
| Brand/Generic | Generic |
| Proprietary Name | Allergy Multi Symptom |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, COATED |
| Route | ORAL |
| Active Ingredient Strength | 325; 2; 5 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
| Labeler Name | AMERISOURCE BERGEN |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 46122-0660-62 (46122066062)
| NDC Package Code | 46122-660-62 |
|---|---|
| Billing NDC | 46122066062 |
| Package | 2 BLISTER PACK in 1 CARTON (46122-660-62) / 12 TABLET, COATED in 1 BLISTER PACK |
| Marketing Start Date | 2020-11-13 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.0859 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | GNP ALLERGY MULTI-SYMPTOM CPLT |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |